Brought to you by 
Coronado nets $26.9mm through public offering
04 Mar 2015
Executive Summary
Coronado Biosciences Inc. (immunotherapeutics for autoimmune diseases and cancer) netted $26.9mm through the public sale of 5.75mm common shares (including the overallotment) at $5 each. The company had originally hoped to sell 2mm shares.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Vaccines
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Coronado nets $26.9mm through public offering
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice